Drug points: Serious interaction between warfarin and oral terbinafine

BMJ

Volumn 316, Issue 7129, 1998, Pages 440-441

  Warwick, J A ^a   Corrall, R J ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; NAPHTHALENE DERIVATIVE; TERBINAFINE; COUMARIN ANTICOAGULANT; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; EAR DISEASE; HUMAN; MALE; PAROTID GLAND DISEASE; TINEA; AGED; EXTERNAL OTITIS; FEMALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN MANIFESTATION; TASTE DISORDER;

ADULT; ANTIFUNGAL AGENTS; EAR DISEASES; HUMANS; MALE; NAPHTHALENES; PAROTID DISEASES; TINEA;

EID: 85007746357     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7129.440     Document Type: Article

References (5)

1. Okino K, Weibert RT. Warfarin-griseofulvin interaction. Drug Intelligence and Clinical Pharmacy 1986; 20: 291–3.
2. Young LY, Koda-Kimble MA. Applied therapeutics. The clinical use of drugs. Vancouver: Applied Therapeutics, 1995.
3. Balfour J, Faulds D. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259–84.
4. Back DJ, Tjia JF. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Br J Clin Pharmacol 1991; 32: 624–626.
5. Long CC, Hill SA, Thomas RC, Holt DW, Finlay AY. The effect of terbinafine on the pharmacokinetics of cyclosporin in vivo. Skin Pharmacol 1992; 5: 200–1